Link to this page
Physician Data Query
| Preferred Name | betamethasone | |
| Synonyms |
Celestone |
|
| Definitions |
A synthetic glucocorticoid with metabolic, immunosuppressive and anti-inflammatory activities. Betamethasone binds to specific intracellular glucocorticoid receptors and subsequently binds to DNA to modify gene expression. The synthesis of certain anti-inflammatory proteins is induced while the synthesis of certain inflammatory mediators is inhibited. As a result, there is an overall reduction in chronic inflammation and autoimmune reactions. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C303" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C303" NCI Thesaurus) |
|
| ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000039273 |
|
| altLabel |
Celestone
|
|
| CAS Registry |
378-44-9
|
|
| cui |
C0701247 C0005308
|
|
| definition |
A synthetic glucocorticoid with metabolic, immunosuppressive and anti-inflammatory activities. Betamethasone binds to specific intracellular glucocorticoid receptors and subsequently binds to DNA to modify gene expression. The synthesis of certain anti-inflammatory proteins is induced while the synthesis of certain inflammatory mediators is inhibited. As a result, there is an overall reduction in chronic inflammation and autoimmune reactions. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C303" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C303" NCI Thesaurus)
|
|
| Legacy PDQ ID |
1903
|
|
| LT |
TRD
|
|
| NCI ID |
C303
|
|
| notation |
CDR0000039273
|
|
| NSC Code |
39470
|
|
| ORIG STY |
Drug/agent
|
|
| prefLabel |
betamethasone
|
|
| tui |
T125 T109 T121
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |